Candel Therapeutics, Inc. (CADL) vs MiMedx Group, Inc (MDXG)
- Candel Therapeutics, Inc. CADL 8.19 −8.08%
- MiMedx Group, Inc MDXG 4.43 −5.34%
Candel Therapeutics, Inc. and MiMedx Group, Inc are both Biotechnology companies. Candel Therapeutics, Inc. and MiMedx Group, Inc are of similar size ($682.2M and $681.8M). Candel Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 111×. Candel Therapeutics, Inc. grew revenue faster over the last twelve months: 0.00% against −2.36%. MiMedx Group, Inc has the higher net margin (1.76% vs 0.00%) and the higher return on invested capital (5.62% vs 0.00%). Across the 17 metrics below, MiMedx Group, Inc leads on 14 and Candel Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | CADL | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.85% | 65.16% |
| Operating margin | 0.00% | 2.46% | 0.00% |
| Net margin | 0.00% | 1.76% | 0.00% |
| Free cash flow margin | 0.00% | 12.51% | 0.00% |
| Return on equity | (81.84%) | 2.88% | (56.36%) |
| Return on assets | (56.37%) | 2.18% | (48.04%) |
| Return on invested capital | 0.00% | 5.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack